171 related articles for article (PubMed ID: 37659859)
1. Projected impact of guidelines on incidence of venous thromboembolism after cesarean delivery in the United States.
Federspiel JJ; Wein LE; Duggal R; Myers ER; Boggess KA; James AH
J Thromb Haemost; 2023 Dec; 21(12):3547-3556. PubMed ID: 37659859
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism incidence among patients recommended for pharmacologic thromboembolism prophylaxis after cesarean delivery in selected guidelines.
Federspiel JJ; Wein LE; Addae-Konadu KL; Darwin KC; Talamo LE; Myers ER; James AH
J Thromb Haemost; 2021 Mar; 19(3):830-838. PubMed ID: 33345404
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
4. Racial and ethnic disparities in eligibility for postpartum venous thromboembolism prophylaxis in the United States.
Campbell AIK; Xu Y; Skeith L; Federspiel JJ
J Thromb Haemost; 2024 Feb; 22(2):545-552. PubMed ID: 37838240
[TBL] [Abstract][Full Text] [Related]
5. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
Galambosi PJ; Ulander VM; Kaaja RJ
Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
[TBL] [Abstract][Full Text] [Related]
6. A comparison of recommendations for pharmacologic thromboembolism prophylaxis after caesarean delivery from three major guidelines.
Palmerola KL; D'Alton ME; Brock CO; Friedman AM
BJOG; 2016 Dec; 123(13):2157-2162. PubMed ID: 26435300
[TBL] [Abstract][Full Text] [Related]
7. A local risk score model for venous thromboembolism prophylaxis for caesarean section in Chinese women and comparison with international guidelines.
Lok WY; Kong CW; To WWK
Taiwan J Obstet Gynecol; 2019 Jul; 58(4):520-525. PubMed ID: 31307744
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer.
Van Matre ET; Reynolds PM; MacLaren R; Mueller SW; Wright GC; Moss M; Burnham EL; Ho PM; Vandivier RW; Kiser TH
J Thromb Haemost; 2018 Dec; 16(12):2492-2500. PubMed ID: 30347498
[TBL] [Abstract][Full Text] [Related]
9. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.
Bates SM; Rajasekhar A; Middeldorp S; McLintock C; Rodger MA; James AH; Vazquez SR; Greer IA; Riva JJ; Bhatt M; Schwab N; Barrett D; LaHaye A; Rochwerg B
Blood Adv; 2018 Nov; 2(22):3317-3359. PubMed ID: 30482767
[TBL] [Abstract][Full Text] [Related]
10. Utilization of venous thromboembolism prophylaxis in American hospitalized pregnant women undergoing cesarean section.
Pon TK; Wessel N; Cagonot V; Delmonte R; Roach D; Finta L
Int J Clin Pharm; 2019 Feb; 41(1):264-271. PubMed ID: 30661217
[TBL] [Abstract][Full Text] [Related]
11. The prevention of pregnancy-related venous thromboembolism.
Guimicheva B; Czuprynska J; Arya R
Br J Haematol; 2015 Jan; 168(2):163-74. PubMed ID: 25312482
[TBL] [Abstract][Full Text] [Related]
12. Impact of thromboprophylaxis across the US acute care setting.
Huang W; Anderson FA; Rushton-Smith SK; Cohen AT
PLoS One; 2015; 10(3):e0121429. PubMed ID: 25816146
[TBL] [Abstract][Full Text] [Related]
13. Thromboembolism incidence and prophylaxis during vaginal delivery hospitalizations.
Friedman AM; Ananth CV; Prendergast E; Chauhan SP; D'Alton ME; Wright JD
Am J Obstet Gynecol; 2015 Feb; 212(2):221.e1-12. PubMed ID: 25240092
[TBL] [Abstract][Full Text] [Related]
14. Assessment of knowledge and practice of venous thromboembolism (VTE) prophylaxis after cesarean section among gynecologists and obstetricians in Al-Najaf hospitals.
Suker SEJ; Al-Meen AAH; Khawwam AA
J Med Life; 2021; 14(5):690-694. PubMed ID: 35027972
[TBL] [Abstract][Full Text] [Related]
15. Estimating the risk thresholds used by guidelines to recommend postpartum thromboprophylaxis.
Gassmann N; Viviano M; Righini M; Fontana P; Martinez de Tejada B; Blondon M
J Thromb Haemost; 2021 Feb; 19(2):452-459. PubMed ID: 33176061
[TBL] [Abstract][Full Text] [Related]
16. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.
Brown A
Am J Health Syst Pharm; 2012 Mar; 69(6):469-81. PubMed ID: 22382477
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological Thromboprophylaxis during Pregnancy and the Puerperium: Recommendations from Current Guidelines and their Critical Comparison].
Rath W; Tsikouras P; von Tempelhoff GF
Z Geburtshilfe Neonatol; 2016 Jun; 220(3):95-105. PubMed ID: 27315397
[TBL] [Abstract][Full Text] [Related]
18. Determining the impact of culture on venous thromboembolism prevention in trauma patients: A Southwestern Surgical Congress Multicenter trial.
Regner JL; Shaver CN;
Am J Surg; 2019 Jun; 217(6):1030-1036. PubMed ID: 30503515
[TBL] [Abstract][Full Text] [Related]
19. Routine use of LMWH prophylaxis is associated with a lower incidence of venous thromboembolic events following an ankle fracture.
Juto H; Hultin M; Möller M; Morberg P
Injury; 2022 Feb; 53(2):732-738. PubMed ID: 34865819
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the use of low-molecular-weight heparin for venous thromboembolism prophylaxis in medical patients.
Du Plessis JA; Van Blydenstein SA; Wong M
S Afr Med J; 2020 Feb; 110(3):235-242. PubMed ID: 32657702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
